Cargando…
EIF2A-dependent translational arrest protects leukemia cells from the energetic stress induced by NAMPT inhibition
BACKGROUND: Nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in NAD(+) biosynthesis from nicotinamide, is one of the major factors regulating cancer cells metabolism and is considered a promising target for treating cancer. The prototypical NAMPT inhibitor FK866 effectively l...
Autores principales: | Zucal, Chiara, D’Agostino, Vito G., Casini, Antonio, Mantelli, Barbara, Thongon, Natthakan, Soncini, Debora, Caffa, Irene, Cea, Michele, Ballestrero, Alberto, Quattrone, Alessandro, Indraccolo, Stefano, Nencioni, Alessio, Provenzani, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636066/ https://www.ncbi.nlm.nih.gov/pubmed/26542945 http://dx.doi.org/10.1186/s12885-015-1845-1 |
Ejemplares similares
-
Cancer cell metabolic plasticity allows resistance to NAMPT inhibition but invariably induces dependence on LDHA
por: Thongon, Natthakan, et al.
Publicado: (2018) -
The GSK3β inhibitor BIS I reverts YAP-dependent EMT signature in PDAC cell lines by decreasing SMADs expression level
por: Thongon, Natthakan, et al.
Publicado: (2016) -
Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
por: Caffa, Irene, et al.
Publicado: (2015) -
Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function
por: D’Agostino, Vito Giuseppe, et al.
Publicado: (2015) -
Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cells
por: Carreira, Agata Sofia Assuncao, et al.
Publicado: (2023)